Provided by Tiger Trade Technology Pte. Ltd.

AKESO

105.700
-3.400-3.12%
Volume:11.04M
Turnover:1.19B
Market Cap:97.35B
PE:-85.74
High:111.500
Open:110.900
Low:104.900
Close:109.100
52wk High:156.000
52wk Low:80.200
Shares:921.00M
HK Float Shares:921.00M
Volume Ratio:1.84
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.233
ROE:-13.59%
ROA:-4.57%
PB:9.80
PE(LYR):-85.74
PS:24.10

Loading ...

Movement Alert|Akeso Bio Falls 3.04% in Regular Trading, Post-ASCO Selling Pressure Resumes After Brief Buyback-Driven Rebound

Market Focus
·
Jun 15

AKESO's Novel Drug AK111 Receives Marketing Authorization from Chinese Regulators for Plaque Psoriasis

Stock News
·
Jun 12

Akeso - Nmpa Approves New Drug Application for Gumokimab (Ak111)

THOMSON REUTERS
·
Jun 12

Movement Alert|Akeso Bio Rises 3.13% in Regular Trading, Board Approves HK$200 Million Buyback Plan and Management Pledges HK$50 Million in Open-Market Purchases

Market Focus
·
Jun 12

Akeso says China NMPA approves gumokimab for moderate-to-severe plaque psoriasis

Reuters
·
Jun 12

Akeso's Trustee, Senior Management to Buy Back Shares

MT Newswires Live
·
Jun 11

Akeso Board Approves HK$200 Million Share Purchase Plan

MT Newswires Live
·
Jun 11

Akeso Announces HK$200.00 Million Share Buyback and HK$50.00 Million Insider Purchases

Bulletin Express
·
Jun 11

AKESO Announces Up to HK$200 Million Share Buyback Plan and Management's Intention to Boost Holdings

Stock News
·
Jun 11

Akeso executives plan share purchases worth up to HK$50 million

Reuters
·
Jun 11

Akeso - Executives to Increase Shareholdings by up to HK$50 Mln on Market

THOMSON REUTERS
·
Jun 11

Akeso - Board Approves up to HK$200 Mln on-Market Share Purchase

THOMSON REUTERS
·
Jun 11

Movement Alert|Akeso Falls 3.24% in Regular Trading, Post-ASCO Sell-Off Extends as Stock Nears 52-Week Low

Market Focus
·
Jun 11

Movement Alert|AKeso Falls 3.35% in Regular Trading, Stock Approaches 52-Week Low as Post-ASCO Selloff Extends Beyond 25%

Market Focus
·
Jun 10

Movement Alert|Akeso Falls 3.36% in Regular Trading, Post-ASCO Profit-Taking Extends Weekly Decline Beyond 20%

Market Focus
·
Jun 09

Domestic Innovative Drugs Initiate Paradigm Shift in First-Line NSCLC Treatment, Says Orient Securities

Stock News
·
Jun 08

AKESO's New Drug Achieves Historic Milestone, Yet Market Cap Plummets by Tens of Billions

Deep News
·
Jun 05

Akeso to Seek 20% Issuance Mandate, 10% Buy-back Authority at 29 June AGM

Bulletin Express
·
Jun 05

AKESO Sets 29 June 2026 AGM to Vote on Director Re-elections, EY Re-appointment and 20% Issuance Mandate

Bulletin Express
·
Jun 05

AKESO Schedules 29 June 2026 AGM; Shareholders to Vote on FY2025 Results, Board Line-up and 20% Issuance Mandate

Bulletin Express
·
Jun 05